Drug Database
Back to search

Italy· 038406017

BENKETOL

A ketorolac product containing ketorolac, registered in Italy by PHARMABER S.R.L., on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC M01AB15

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedBENKETOLATCM01AB15REGISTER NO.038406017PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ketorolacAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ketorolac is registered in 9 of 19 countries.

Countries holding a registration under ATC M01AB15 (ketorolac), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 6 of them publish a price we can compare per daily dose
Search ketorolac products by name

Ketorolac · ATC M01AB15

9 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Italyprice
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Ketorolac
Manufacturer
PHARMABER S.R.L.
Country
Italy (IT)
ATC code
M01AB15
ATC class
Ketorolac
Defined daily dose
30 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    038406017
    "30 MG/ML SOLUZIONE INIETTABILE" 3 FIALE DA 1ML
    EUR 2.16

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for ketorolac.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ketorolac against other medicinesHow interaction checks work

Ketorolac · interactions on record

378 records

  • 69 severe
  • 129 moderate
  • 5 minor
  • 94 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ketorolac in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ketorolac products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Acular, Ketorolac Micro Labs
  • Belgium · Aculare, Taradyl
  • Bulgaria · Кетоажур, Кеторолак Вижън
  • Cyprus · Errkes
  • Czechia · Ketorolac Trometamol Brown & Burk
  • Germany · Ketorolac Micro Labs, Ketovision
  • Denmark · Acular, Caloket
  • Estonia · Ketorolac Baxter
  • Spain · Acular, Ketorolaco Kabi
  • Finland · Caloket, Ketorolac S.A.L.F.
  • France · Acular
  • United Kingdom (Northern Ireland) · Acular, Ketorolac Trometamol Baxter Healthcare
  • Greece · Acular, Errkes
  • Ireland · Acular
  • Iceland · Toradol
  • Lithuania · Ketanov, Ketorolac Baxter
  • Luxembourg · Aculare, Taradyl
  • Latvia · Ketanov, Ketorolac Baxter
  • Norway · Caloket, Ketorolac Trometamol S.A.L.F.
  • Poland · Ketorolac Trometamol Brown & Burk
  • Portugal · Acular, Cetorolac
  • Romania · Ketanov, Ketorol
  • Sweden · Caloket, Ketorolac S.A.L.F.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4aff74b-6c65-4f00-8c6d-aef3baece778
GET /v1/drugs/d4aff74b-6c65-4f00-8c6d-aef3baece778?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"30 MG/ML SOLUZIONE INIETTABILE\" 3 FIALE DA 1ML",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Ketorolac",
  "reference_pack": "3 UNITA' 30 MG - USO PARENTERALE",
  "public_price_eur": 2.16,
  "ssn_reference_price_eur": 2.98
}
API referenceMCP serverPlans

See everything about ketorolac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console